Uranium developer Cameco (CCJ+5.8%) is praised in two analyst reports. Seeing potential ~50% share upside, Gabelli finds CCJ "particularly compelling given its attractive asset base and project development pipeline." TD believes "the improved tone in the uranium market should translate into higher prices for the commodity later this year."